|
Market Closed -
Nasdaq Stockholm
02:00:00 03/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 511.50 SEK | -0.39% |
|
-3.03% | -6.83% |
| 15/09 | Odin Small Cap rose 4.15% in August, 16 holdings beat expectations | FW |
| 09/09 | PriorNilsson Evolve Global rose 0.49 percent in August, increased exposure to Kitron and Scanfil | FW |
Company Valuation: MedCap AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,997 | 8,899 | 8,278 | 7,660 | - | - |
| Change | - | 78.07% | -6.99% | -7.46% | - | - |
| Enterprise Value (EV) 1 | 4,997 | 9,176 | 8,359 | 7,743 | 7,505 | 7,265 |
| Change | - | 83.61% | -8.9% | -7.37% | -3.07% | -3.2% |
| P/E | 29.1x | 42.9x | - | 30.1x | 25.6x | 22.6x |
| PBR | - | 6.95x | - | 4.47x | 3.8x | 3.25x |
| PEG | - | 2.1x | - | - | 1.5x | 1.7x |
| Capitalization / Revenue | - | 4.93x | 3.93x | 3.19x | 2.85x | 2.62x |
| EV / Revenue | - | 5.08x | 3.97x | 3.23x | 2.79x | 2.48x |
| EV / EBITDA | - | 23.7x | 18.3x | 14x | 11.9x | 10.5x |
| EV / EBIT | - | 33.7x | 27.6x | 20.9x | 17.2x | 15.2x |
| EV / FCF | - | 28.8x | 26.4x | 41.9x | 20.9x | 17.7x |
| FCF Yield | - | 3.47% | 3.79% | 2.39% | 4.78% | 5.66% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 11.6 | 14 | - | 16.97 | 19.95 | 22.62 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 1,807 | 2,108 | 2,398 | 2,686 | 2,927 |
| EBITDA 1 | - | 387.7 | 456.3 | 551.5 | 632 | 694 |
| EBIT 1 | - | 272.3 | 302.9 | 370 | 437 | 479.5 |
| Net income 1 | 172.2 | 207.4 | 219.8 | 258 | 319 | 356 |
| Net Debt 1 | - | 276.5 | 81.3 | 83 | -155 | -395.5 |
| Reference price 2 | 337.50 | 601.00 | 549.00 | 511.50 | 511.50 | 511.50 |
| Nbr of stocks (in thousands) | 14,807 | 14,807 | 15,078 | 14,976 | - | - |
| Announcement Date | 31/1/24 | 31/1/25 | 5/2/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 3.23x | 14.04x | - | 763M | |
| 19.32x | 5.52x | 11.8x | 2.16% | 164B | |
| 13.71x | 3.37x | - | 2.57% | 146B | |
| 15.75x | 7.18x | - | 1.59% | 98.65B | |
| 18.64x | 6.58x | 11.94x | 4.6% | 89.39B | |
| 24.21x | 7.78x | 11.44x | 0.87% | 81.05B | |
| 21.05x | 11.27x | 18.06x | 4.49% | 71.54B | |
| 13.09x | 5.13x | - | 1.99% | 48.34B | |
| 10.77x | 1.59x | 4.92x | 1.36% | 43.36B | |
| Average | 17.07x | 5.74x | 12.03x | 2.45% | 82.57B | |
| Weighted average by Cap. | 17.45x | 5.99x | 12.10x | 2.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MCAP Stock
- Valuation MedCap AB
Select your edition
All financial news and data tailored to specific country editions
